News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ImmunoGen, Inc. (IMGN) Announces Conference Call to Discuss its Third Quarter Fiscal Year 2013 Financial Results


4/18/2013 7:16:13 AM

ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer therapeutics, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, April 26, 2013, to discuss ImmunoGen's financial results for the three-month period ended March 31, 2013 – the third quarter of the Company’s 2013 fiscal year.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES